Authors
Sevda Boyanova, Loukia Katsouri, Julija Krupic, Kaitlyn Hair, Szu-Han Wang, Frances K Wiseman
Published in
STAR protocols. Volume 7. Issue 3. Pages 104633. Jun 16, 2026. Epub Jun 16, 2026.
Abstract
All models are incomplete and must balance the need for experimental efficiency with the complexity of the natural world. To select and use models for the study of human disease, it is critical to understand what is of fundamental scientific importance and which limitations are thus of greatest concern. Here, we highlight key considerations for the design of research studies using mouse models of aspects of Alzheimer's disease for both mechanistic and proof-of-principle intervention studies. This primer considers mouse model choice, including the strengths and limitations of genetically altered, pathological aggregates injection, and human iPSC-chimera systems. We also review key principles of experimental design, husbandry, and technical considerations for the phenotyping of clinically disease-relevant features, with a focus on behavior and cognition.
PMID:
42301821
Bibliographic data and abstract were imported from PubMed on 17 Jun 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0